Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2016-10-06

Clinical Trial Update: Identifying Risk Factors for Eczema Herpeticum in Individuals With Atopic Dermatitis

View source ↗

Summary

A completed clinical trial evaluating risk factors for eczema herpeticum in individuals with atopic dermatitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Atopic Dermatitis, Eczema Herpeticum | Status: COMPLETED